These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 27830156)

  • 1. Administration of Traditional Chinese Blood Circulation Activating Drugs for Microvascular Complications in Patients with Type 2 Diabetes Mellitus.
    He L; Wang H; Gu C; He X; Zhao L; Tong X
    J Diabetes Res; 2016; 2016():1081657. PubMed ID: 27830156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Research advances on astragaloside-IV in treatment of diabetes mellitus and its complications pharmacological effects].
    You LZ; Lin YX; Fang ZH; Shen GM; Zhao JD; Wang TT
    Zhongguo Zhong Yao Za Zhi; 2017 Dec; 42(24):4700-4706. PubMed ID: 29493134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of cilostazol in treating diabetes-associated microvascular complications.
    Asal NJ; Wojciak KA
    Endocrine; 2017 May; 56(2):240-244. PubMed ID: 28293857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of sarpogrelate on microvascular complications with type 2 diabetes.
    Yoo H; Park I; Kim DJ; Lee S
    Int J Clin Pharm; 2019 Apr; 41(2):563-573. PubMed ID: 30864083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stationary Treatment Compared with Individualized Chinese Medicine for Type 2 Diabetes Patients with Microvascular Complications: Study Protocol for a Randomized Controlled Trial.
    Huo J; Liu LS; Jian WY; Zeng JP; Duan JG; Lu XJ; Yin S
    Chin J Integr Med; 2018 Oct; 24(10):728-733. PubMed ID: 29915910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Experimental research progress in traditional Chinese medicine prevention and treatment of diabetic peripheral neuropathy based on autophagy].
    Huang SS; Wang XR; Yuan JS; DU L
    Zhongguo Zhong Yao Za Zhi; 2023 Dec; 48(23):6315-6323. PubMed ID: 38211988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential Roles of Anti-Inflammatory Plant-Derived Bioactive Compounds Targeting Inflammation in Microvascular Complications of Diabetes.
    Kaabi YA
    Molecules; 2022 Oct; 27(21):. PubMed ID: 36364178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AGEs, rather than hyperglycemia, are responsible for microvascular complications in diabetes: a "glycoxidation-centric" point of view.
    Chilelli NC; Burlina S; Lapolla A
    Nutr Metab Cardiovasc Dis; 2013 Oct; 23(10):913-9. PubMed ID: 23786818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Review of Traditional Chinese Medicine on Treatment of Diabetic Nephropathy and the Involved Mechanisms.
    Liu XJ; Hu XK; Yang H; Gui LM; Cai ZX; Qi MS; Dai CM
    Am J Chin Med; 2022; 50(7):1739-1779. PubMed ID: 36222120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AMPK in microvascular complications of diabetes and the beneficial effects of AMPK activators from plants.
    Shrikanth CB; Nandini CD
    Phytomedicine; 2020 Jul; 73():152808. PubMed ID: 30935723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How to prevent the microvascular complications of type 2 diabetes beyond glucose control.
    Valencia WM; Florez H
    BMJ; 2017 Jan; 356():i6505. PubMed ID: 28096078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances of traditional Chinese medicine preclinical mechanisms and clinical studies on diabetic peripheral neuropathy.
    Zhang Y; Wu X; Yao W; Ni Y; Ding X
    Pharm Biol; 2024 Dec; 62(1):544-561. PubMed ID: 38946248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of serum vitamin D levels with diabetic microvascular complications in patients with type 2 diabetes mellitus.
    Zhao WJ; Xia XY; Yin J
    Chin Med J (Engl); 2021 Feb; 134(7):814-820. PubMed ID: 33538508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of the systemic immuno-inflammation index, neutrophil-to-lymphocyte ratio, and platelet-to-lymphocyte ratio with diabetic microvascular complications.
    Li J; Wang X; Jia W; Wang K; Wang W; Diao W; Ou F; Ma J; Yang Y
    Front Endocrinol (Lausanne); 2024; 15():1367376. PubMed ID: 38660516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetic late complications: will aldose reductase inhibitors or inhibitors of advanced glycosylation endproduct formation hold promise?
    Boel E; Selmer J; Flodgaard HJ; Jensen T
    J Diabetes Complications; 1995; 9(2):104-29. PubMed ID: 7599349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual CCR2/CCR5 antagonist treatment attenuates adipose inflammation, but not microvascular complications in ob/ob mice.
    O'Brien PD; Hinder LM; Parlee SD; Hayes JM; Backus C; Zhang H; Ma L; Sakowski SA; Brosius FC; Feldman EL
    Diabetes Obes Metab; 2017 Oct; 19(10):1468-1472. PubMed ID: 28332276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial dysfunction in diabetic nephropathy: insights and therapeutic avenues from traditional Chinese medicine.
    Zhao DM; Zhong R; Wang XT; Yan ZH
    Front Endocrinol (Lausanne); 2024; 15():1429420. PubMed ID: 39109083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of clinical evidence on traditional Chinese medicine for the treatment of diabetic nephropathy: a comprehensive review with evidence mapping.
    Gao Y; Li Z; Wang Y; Zhang H; Huang K; Fu Y; Xu S; Li Q; Liu X; Zhang G
    Front Endocrinol (Lausanne); 2024; 15():1324782. PubMed ID: 38601203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of ADMA in the pathogenesis of microvascular complications in type 2 diabetes mellitus.
    Guo X; Xing Y; Jin W
    Front Endocrinol (Lausanne); 2023; 14():1183586. PubMed ID: 37152974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A clinical study on treatment of vascular complications of diabetes with the sugar--reducing and pulse--invigorating capsule.
    Lin L; Zhang H; Gao Q; Ma J
    J Tradit Chin Med; 1994 Mar; 14(1):3-9. PubMed ID: 8196413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.